Fig. 17
From: Edaravone ameliorates depressive and anxiety-like behaviors via Sirt1/Nrf2/HO-1/Gpx4 pathway
Schematic illustration of the proposed mechanisms underlying EDA-related antidepressant and anxiolytic efficacy
Fig. 17 | Journal of Neuroinflammation